Catriona Yale serves as Executive at Akero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Catriona Yale has executed 66 insider transactions totaling $7.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2022 involved selling 4,598 shares valued at $198.5K.
Catriona Yale currently holds 74,800 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catriona Yale has been a net seller of AKRO stock. They have purchased $0 and sold $7.4M worth of shares.
Catriona Yale's most recent insider trade was on Dec 12, 2022, when they sold 4,598 shares at $43.18 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 10, 2022 | AKRO | $4.0K | Sale | 100 | $39.96 | Discretionary |
| Nov 10, 2022 | AKRO | $193.1K | Sale | 4,900 | $39.41 | Discretionary |
| Oct 10, 2022 | AKRO | $189.9K | Sale | 5,000 | $37.99 | Discretionary |
| Sep 13, 2022 | AKRO | $707.1K | Sale | 26,014 | $27.18 | Discretionary |
| Sep 13, 2022 | AKRO | $392.2K | Sale | 13,986 | $28.04 | Discretionary |
| Jun 30, 2022 | AKRO | $9.3K | Award | 1,152 | $8.03 | Discretionary |
| Oct 15, 2021 | AKRO | $267.6K | Sale | 12,400 | $21.58 | Discretionary |
| Oct 15, 2021 | AKRO | $2.2K | Sale | 100 | $22.34 | Discretionary |
| Sep 15, 2021 | AKRO | $258.0K | Sale | 10,500 | $24.57 | Discretionary |
| Sep 15, 2021 | AKRO | $50.6K | Sale | 2,000 | $25.31 | Discretionary |
| Aug 16, 2021 | AKRO | $187.9K | Sale | 10,000 | $18.79 | Discretionary |
| Jul 15, 2021 | AKRO | $209.0K | Sale | 10,000 | $20.90 | Discretionary |
| Jun 30, 2020 | AKRO | $21.3K | Award | 1,245 | $17.07 | Discretionary |
| Dec 31, 2019 | AKRO | $19.3K | Award | 1,025 | $18.87 | Discretionary |